SCHEMBL4048712

SCHEMBL4048712

c1cnc2nc(C3CCC3)[nH]c2c1

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NPY5R Q15761 1/20 0.55
SMO Q99835 1/20 0.51
NUDT1 P36639 1/20 0.50
PDE5A O76074 3/20 0.47
PDE4A P27815 2/20 0.47
PDE4B Q07343 2/20 0.47
PDE4C Q08493 2/20 0.47
PDE4D Q08499 2/20 0.47
METAP1 P53582 2/20 0.45
METAP2 P50579 1/20 0.45
AURKA O14965 3/20 0.45
ALDH1A1 P00352 1/20 0.44
POLB P06746 1/20 0.44
MAPT P10636 1/20 0.44
HPGD P15428 1/20 0.44
TSHR P16473 1/20 0.44
AKT1 P31749 2/20 0.43
AKT2 P31751 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7583531 0.95 NPY5R (0.54) NPY5RSMONUDT1PDE5APDE4A
SCHEMBL4111938 0.93 NPY5R (0.57) NPY5RSMONUDT1PDE5APDE4A
SCHEMBL14447540 0.87 NPY5R (0.53) NPY5RSMONUDT1PDE5APDE4A
SCHEMBL20284753 0.85 PARP1 (0.56) NPY5RNUDT1AURKA
SCHEMBL5016405 0.79 AKT1 (0.61) NPY5RSMOALDH1A1AKT1AKT2
SCHEMBL19377868 0.75 GRIN2B (0.44) NPY5RSMOALDH1A1POLBAKT1
SCHEMBL4059999 0.74 METAP2 (0.38) NPY5RMETAP1METAP2MAPT
SCHEMBL2674802 0.74 HTR2B (0.55) NPY5RPOLBMAPT
SCHEMBL31690853 0.73 NPC1 (0.41) MAPT
SCHEMBL3951535 0.73 NPC1 (0.41) MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009029625-A1 4- [HETEROCYCLYL-METHYL] -8-FLUORO-QUINOLIN-2-ONES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS KALYPSYS, INC. (US) 2009-03-05 WO disclosed
WO-2009029625-A1 4- [HETEROCYCLYL-METHYL] -8-FLUORO-QUINOLIN-2-ONES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS KALYPSYS, INC. (US) 2009-03-05 WO disclosed